ACTRN12618001152213进行中（未招募）未知
A multi-centre, waitlist randomised controlled trial of patient navigators to improve the overall self-rated health in children with chronic kidney disease
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 162
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Educational / counselling / training
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- Years 至 16 Years（—）
- 性别
- All
入选标准
- •Specifically, to be eligible for the study, participants must satisfy all of the below criteria:
- •1. Children with CKD (1-5), or CKD-D or CKD-T,
- •2. Aged 0-16 years, and
- •3. Low SES background and/or living in rural/remote areas . Low SES families are defined as the following: a. Weekly household income (less than the median gross household income, $1250 (AUD) per week), b. Just getting along, poor or very poor self-perceived financial status, c. Single parenting on social benefits, d. Both parents are unemployed, e. Families living in public housing.
- •Rural/remote areas are classified as having post code in RA2-RA5 area.
- •4. Caregiver(s) speak English or caregiver(s) speaks a little English but has a family member who can speak English
- •5. Able to provide consent by the caregiver (and assent- if the child is of 16 years of age)
- •6. Only one sibling from a family can be included in the study
排除标准
- •1. Limited life expectancy of less than 12 months
研究者
相似试验
已完成
不适用
Prospective, multicenter randomized controlled trial of the self-assembling hemostatic gel PuraStat to prevent delayed bleeding after endoscopicresectionsK63.5K31.7Polyp of colonPolyp of stomach and duodenumDRKS00028119Asklepios Kliniken Hamburg GmbH Vertreten durch ASKLEPIOS proresearch Lohmühlenstraße 5 Haus J-D20099248
已完成
不适用
Evaluation of primary hospital educational interventioClinical guidelines of the treatment of acutely poisoned patientsClinical guidelinesISRCTN73983810South Asian Clinical Toxicology Research Collaboration (SACTRC) (Sri Lanka)42
招募中
4 期
A multicenter, randomized, open and controlled trial for the efficacy and safety of Kang-Bing-Du granules in the treatment of novel coronavirus pneumonia (COVID-19)ovel Coronavirus Pneumonia (COVID-19)ITMCTR2000003005nion Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
招募中
1 期
A multicenter, randomized, controlled clinical trial of Hydroxychloroquine or new Tripterygium compound in the treatment of IgA nephropathyIgA nephropathyITMCTR2100004723Peking University First Hospital
招募中
1 期
A multicenter, randomized, controlled clinical trial of efficacy and safety of xinan Guben Peiyuan formula series in the treatment of COPDChronic obstructive pulmonary diseaseITMCTR2200005834The First Affiliated Hospital of Anhui University of Chinese Medicine